---
title: "CJC-1295"
description: "CJC-1295 is a GHRH analog that amplifies and prolongs the GH pulse triggered by GHRPs. The \"no DAC\" version (Mod GRF 1-29) should be injected with every GHRP. The DAC version has an 8-day half-life but gives a less physiological GH plateau."
lang: en
dateModified: 2026-05-25
canonical: https://anaprotokol.com/en/molecule/cjc1295
---

# CJC-1295

CJC-1295 is a GHRH analog that amplifies and prolongs the GH pulse triggered by GHRPs. The "no DAC" version (Mod GRF 1-29) should be injected with every GHRP. The DAC version has an 8-day half-life but gives a less physiological GH plateau.

**Catégorie** : Peptide
**Voie d'administration** : Injectable
**Demi-vie** : 30 min (sans DAC) / 8 jours (avec DAC)
**Détection** : Non détecté usuellement
**Aromatisation** : Non
**Progestine** : Non
**Hépatotoxique** : Non
**PCT requise** : Non

**Autres noms** : CJC-1295, DAC

## Effets
- Amplification of the GH pulse
- Sustained IGF-1 increase
- Recovery ++
- Lipolysis
- Sense of well-being

## Effets secondaires
- Mild water retention
- Numbness
- Facial flush
- Mild hypoglycemia post-injection

## Suppléments de soutien
- GHRP-2 or GHRP-6 or Ipamorelin (mandatory for synergistic effect)

## Synergies
- GHRP-2
- GHRP-6
- Ipamorelin
- MK-677

## À éviter
- Without a GHRP (CJC alone = limited effect)
- With meals (no-DAC version)

## Dosage masculin
- Débutant : 100 mcg × 2/j
- Intermédiaire : 100 mcg × 3/j
- Avancé : 100–200 mcg × 3/j

## Dosage féminin
100 mcg × 2/day

**Fréquence** : No DAC: with each GHRP · With DAC: 1× / week